SRC and glioblastoma: In glioblastoma (GBM), knockdown or inhibition of PKCiota significantly suppressed tumor growth and prolonged survival time in animal models, PKCiota and SRC signaling were reciprocally related, and a combination of the PKCiota inhibitor auranofin and an SRC signaling inhibitor showed prolonged survival [18].